Pharmacy's digital land grab
Australia's pharmacy sector is moving faster on digital health than most people realise. The nation's top five chains, Chemist Warehouse, TerryWhite Chemmart, Priceline, Amcal, and Discount Drug Stores, are all building digital health ecosystems in their own way. Not as add-ons, but as core business strategy.
TerryWhite has telehealth, two-hour delivery, and a retail media network. Amcal is running clinical data platforms and premium health clinics inside pharmacies. Priceline and Discount Drug Stores are integrating medication management with loyalty. Chemist Warehouse is expanding into optometry and hospital pharmacy. Everyone is repositioning, away from being a shop, toward being a health platform.
The Australian pharmacy market is a behemoth, worth roughly $29.6 billion. Digital health is expected as baseline, and the chains moving fastest are already reshaping how pharmacy competes.
This analysis maps what each of the top five is actually doing, where the gaps are, and where the opportunities sit for healthtech vendors, investors, and service providers.
The landscape just got smaller
Before going chain by chain, the ownership picture matters, because it changed dramatically in early 2025.
In February 2025, Sigma Healthcare and Chemist Warehouse merged. That single deal put Chemist Warehouse, Amcal, and Discount Drug Stores under one roof. The merged group now supports more than 880 franchised pharmacies and supplies over 3,500 across Australia. Three of the five chains in this analysis now share a parent.
Guardian is gone, with Sigma phasing the brand out entirely, folding every store into Amcal by mid-2024. My Chemist also finished converting to Amcal+ in late 2025.
The real structure today: three conglomerates own Australian pharmacy. Sigma (Chemist Warehouse, Amcal, Discount Drug Stores), EBOS (TerryWhite Chemmart), and Wesfarmers, which owns Priceline through its API subsidiary and Wesfarmers Health division. The Bunnings and Kmart owner has been in pharmacy since 2022, and it brings serious loyalty-data and supply-chain muscle.
1. Chemist Warehouse
The numbers: Australia's largest pharmacy retailer, with 580+ stores in Australia (with a stated target of 900), and the anchor of the Sigma merger. The positioning: aggressive pricing, enormous range, and a relentless physical and international expansion engine.
The digital health play is vertical, not horizontal. Chemist Warehouse isn't chasing a slick consumer app, it's buying and building adjacent infrastructure. Optometrist Warehouse launched in 2023. A hospital pharmacy joint venture with Cathie Reid and Stuart Giles is building a network of hospital-based pharmacies. A medicinal cannabis distribution deal with Wellnex Life gave it a national distribution play in the category. And the international footprint keeps growing, now to Ireland, UAE, China and the UK.
The one place Chemist Warehouse is moving fast on technology is operations. In a $18 million partnership with US spatial-AI firm Augmodo, store staff wear SmartBadges that scan shelves as they walk the floor, building live 3D store maps and real-time inventory data. It cut inventory gaps by 30% in the first month of the pilot, and is scaling from four trial stores to more than 550 over two years. A parallel supplier program, SpatialView, opens that shelf data to Chemist Warehouse's brand partners, extending into promotion and pricing compliance through 2026, which is a quiet step toward monetising store data, the same retail-media logic TerryWhite is chasing from a different angle.
The strategy is consolidating healthcare touchpoints. Be the place patients go for scripts, eye care, and hospital transition. Don't win on app polish, win on owning more of the patient's healthcare footprint. The merger with Sigma also hands it the Amcal and DDS digital stack, so it doesn't necessarily need to build its own consumer platform from scratch.
The gap: For the biggest retailer in the country, the consumer-facing digital health story is the thinnest of the five. That's either a deliberate choice or an opening, depending on how you read it (generally in Australia, it’s the latter).
2. TerryWhite Chemmart
~630 franchised pharmacies. Around $740 million revenue. 2024 'Retailer of the Year'. Owned by EBOS, TerryWhite is playing the most comprehensive digital game of anyone on this list.
The myTWC app handles medication management. CareClinic delivers in-store health services, vaccinations, screenings, pain and weight management. A partnership with Hola Health puts on-demand GP appointments inside the app and the Healthengine booking flow. A DoorDash partnership runs two-hour prescription delivery across nearly 400 stores. TWC Connect, launched July 2024, is a retail media network selling brands access to customers along their health journey. Underneath it all sits EBOS's long-standing stake in MedAdvisor, which builds the customised myTWC app.
This is ecosystem thinking, with telehealth, delivery, health services, retail media, all stitched together. Multiple revenue streams, multiple touchpoints. They're not running a pharmacy, more so a health hub. They even heavily use StrongRoom, to streamline medication management platform.
In 2026 it went deeper on clinical tech, rolling out Oexa's Light platform (bookings, prescribing, vaccination records, all wired to national health infrastructure) and layering Heidi’s AI medical scribe over it, giving pharmacists real-time clinical documentation across the 630-store network as they take on more full-scope clinical work.
The DoorDash move is the standout. Two-hour prescription delivery quietly repositions pharmacy as an urgent-convenience point, competing on speed in a way the category hasn't before. This is the most aggressive digital health strategy of the five, and the clearest template for where the sector is heading.
3. Priceline Pharmacy
Around 420 community pharmacies, owned by Wesfarmers through its API subsidiary and Wesfarmers Health division. The approach: measured and practical, with a beauty-and-health retail identity no other chain has, and a conglomerate parent (Bunnings, Kmart, Officeworks, Flybuys) sitting behind it.
The medication management app covers reminders, eScript refills, and prescription tracking. And they also use the StrongRoom platform to track re all drug register transactions, opioid replacement therapy and staged supply services. eScript support runs across participating stores, and pharmacy services booking came live this year, alongside a digital loyalty card and OnePass rewards integration. Priceline runs a dual-app setup, one for medication management, one for shopping and beauty, which mirrors its omnichannel positioning.
Priceline is focused on medication adherence and prescription convenience first, clinical services second. Less aggressive than TerryWhite, but deliberate.
The positioning is distinct: not trying to be a healthcare hub, trying to be the easiest place to manage scripts while owning the health-and-beauty crossover. That loyalty-plus-medication dataset is genuinely differentiated, few chains can connect beauty purchase behaviour to health data the way Priceline can, and with Wesfarmers' loyalty infrastructure behind it (OnePass, Flybuys), the data advantage runs deeper than the pharmacy banner alone.
4. Amcal
Sigma's flagship retail-led banner, now absorbing the old Guardian and My Chemist networks. Trading on more than 85 years of heritage and a 2024 Canstar Blue Most Satisfied Customers award. The positioning: clinical depth and trusted pharmacist advice, not discount-driven convenience.
The Amcal app (built on MedAdvisor, last updated March 2026) is the digital backbone. It auto-builds a medication list that updates every time a script is filled, offers tap-to-refill ordering, manages paper scripts, eScript tokens and the Active Script List, and includes a Carer Mode for managing medications on behalf of someone else, plus a "Track My Results" view for health monitoring and vaccinations done in-store. Appointment booking runs through a Healthengine integration.
But the real story is the clinical services menu, which is where Amcal is making its bet. The brand has built out a structured suite of pharmacist-led consultations: a Sleep Health consultation with at-home sleep apnoea testing and CPAP pathways, a Diabetes Management Review (on-the-spot HbA1c finger-prick test covering heart, kidney, weight, sleep, foot and eye health), an Annual Health Check pitched explicitly around preventative screening, plus weight management, pain management, quit-smoking, eczema care, digestive health checks, UTI treatment, and the full vaccination slate (flu, COVID, travel, whooping cough, MMR). Many of these are bookable online.
The strategy is clinical leadership. Pharmacist expertise as the differentiator, structured health consultations as the proof point. Where TerryWhite is racing on convenience and delivery, Amcal is going deep on the pharmacist-as-clinician model, positioning the pharmacy counter as a genuine first stop for screening and chronic disease management. It's less aggressive on delivery and retail media, more focused on depth than reach. A different bet, and now backed by the scale of the merged Sigma group sitting behind it.
5. Discount Drug Stores
Sigma's value banner, sitting alongside Amcal in the franchise network and now part of the merged Chemist Warehouse group. Positioned exactly where the name suggests, affordability-first, value-conscious customers, no-frills health retail.
The digital footprint is leaner but real. The Discount Drug Stores app, built on MedAdvisor like much of the EBOS and Sigma ecosystem, handles eScripts and medication management, prescription ordering, pick-up scheduling, and ordering of non-prescription medicines, vitamins, and NDSS diabetes items. ePrescribing support has been in the app since 2020. The DiscountPlus loyalty program ties purchase behaviour back to the customer record.
DDS matters in this analysis less for standout innovation and more for what it represents: the value end of the market now has the same baseline digital plumbing, eScripts, app-based ordering, loyalty, as the premium banners. That's the real story of the sector. Digital health capability has stopped being a premium differentiator and become the floor.
The watch-point is execution. App reviews flag the usual friction, freezing, failed uploads, clunky onboarding, the same complaints that dog most MedAdvisor-built pharmacy apps. The platform exists. Whether it's good enough to drive loyalty rather than just tick a box is the open question, and it's the question that creates room for better vendors.
The physical frontier: Robots, health stations and 24-hour dispensing
The most established automation in Australian pharmacy sits where you can't see it: behind the counter. Robotic dispensing systems, most commonly the German-made BD Rowa, now run in hundreds of pharmacies and hospitals across the country, with 370-plus installations to date. These are the large storage-and-retrieval robots tucked into the dispensary that hold the bulk of a pharmacy's stock, pick medications on demand, manage inventory and expiry dates automatically, and hand the script to the pharmacist in seconds. The pitch is simple, take the manual labour out of dispensing so pharmacists spend less time hunting through shelves and more time advising patients. For a sector pushing into clinical services, that freed-up time is the whole point.
If dispensing automation sits at the back, screening automation now sits at the front. Priceline has run SiSU Health self-service health stations in its stores since 2015, the walk-up kiosks that measure blood pressure, heart rate, BMI, body-fat percentage and diabetes risk in about five minutes, then push the results to the customer's app to track over time. The footprint is serious: stations in around 258 Priceline stores nationwide, and more than 755,000 health checks logged. It's also no longer a third-party arrangement. Wesfarmers acquired SiSU Health outright, folding it into the Wesfarmers Health division alongside Priceline and InstantScripts. That's a telling move: the same owner now controls the pharmacy, the telehealth script engine, and the in-store screening data. The health station stops being a novelty at the front of the shop and becomes a data front door into a wider health ecosystem.
What's newer again is pushing automation to the customer-facing edge of dispensing itself. In late 2024, TerryWhite Chemmart Arana Hills in Queensland installed two of Australia's first 24-hour pharmaceutical vending machines, one for prescription pick-up, one for the after-hours essentials people would rather buy in private. Down in Clare, South Australia, another TerryWhite franchisee installed Australia's first outdoor BD Rowa dispensing robot. Customers order through the Terry White app, a robot picks and packs the script, and it's delivered through an ATM-style hole in the wall after scanning a QR code. The pitch is rural access and after-hours convenience: no more hour-long drives or packing sick kids into the car for a script run.
Here's the telling part: the behind-the-counter robots and the front-of-store health stations are mainstream, but customer-facing dispensing is still bubbling up from entrepreneurial franchisees, not being rolled out top-down by the chains. Nobody has made 24-hour automated pick-up a network-wide strategy yet. That's the gap. The first chain to scale it across its network, tied to its app, gets a genuine convenience moat, the physical counterpart to TerryWhite's two-hour delivery play. The dispensary robots proved the technology works. The health stations proved customers will use self-service. The opportunity now is making the dispensing side systematic.
The pattern
Five chains, but really three strategic bets.
Convenience-first: TerryWhite, telehealth, delivery, media network. Clinical-first: Amcal, data platforms, health clinics, pharmacist enablement. Adjacent-services-first: Chemist Warehouse, optometry, hospital pharmacy, international expansion. Priceline and DDS sit in the convenience-first lane too, but lighter, focused on adherence and loyalty rather than the full TerryWhite stack.
What they all share: app-based eScript management, loyalty integration, and digital convenience are now baseline. Not a competitive edge. The floor.
What they don't share: how they think value gets created next. One is building a health ecosystem. One is building clinical infrastructure. One is consolidating physical touchpoints. And much of it now runs through a single owner. The Sigma merger means Chemist Warehouse, Amcal, and DDS could, in theory, converge onto shared digital and data infrastructure. If that happens, the competitive picture shifts from five chains to three conglomerate ecosystems, with Sigma the largest by far.
The gaps
Despite all the activity, the white space is real:
Clinical AI. Adherence prediction, drug interaction flagging, and risk stratification are maturing globally. None of the five have publicly committed to a named AI clinical product at scale. That's a lane wide open.
Retail media beyond TerryWhite. Only TWC Connect has launched. With the Sigma group sitting on Chemist Warehouse, Amcal, and DDS customer data, the most valuable un-built retail media network in Australian pharmacy is theirs to build. Nobody has.
Interoperability. The interface between pharmacy, hospitals, GPs, and community health is still broken. No chain has committed to being the connector layer. Whoever solves it owns the patient journey.
App quality. Most chains run MedAdvisor-built apps with similar friction complaints. The patient-facing experience is a commodity right now, and a mediocre one. There's a real opening for a vendor that makes pharmacy apps genuinely good.
Personalised health campaigns. Chains now hold loyalty data plus medication data. Almost none of them are using it for predictive, personalised health engagement. The dataset exists. The activation doesn't.
Pharmacist enablement. As chains push from dispensing into health services, the tooling for training, clinical workflow, and scope-of-practice expansion is thin. Amcal's PharmacyiQ is one attempt. The market needs more.
What this means for healthtech vendors
Chains are spending in three places, clinical data depth, last-mile convenience, and pharmacist enablement. Whoever brings the better platform wins loyalty and data advantage.
Clinical data integration is the highest-value play. Amcal's clinical-services build-out and TerryWhite's telehealth wiring signal demand for deeper platforms, EHR integration, adherence monitoring, chronic disease management, outcomes tracking. That's where the margin is.
Better patient-facing apps are an underrated entry point. The incumbents are running commoditised, friction-heavy apps. A genuinely good experience, fast, reliable, useful, would be a real wedge, especially with a group like Sigma that now has to unify multiple banner apps.
Personalised engagement tooling sits right behind it. Retail media plus loyalty plus medication data is a powerful combination almost nobody is activating well. Build the layer that turns that data into health outcomes and revenue.
And don't sleep on the unglamorous stuff. Pharmacist training platforms, supply chain and inventory AI across hundreds of variable-demand stores, and multi-jurisdictional compliance tech are all real budgets, and far more defensible than another me-too consumer app.
What's next
Australia's pharmacy sector is mid-transformation. Digital health has stopped being a differentiator and become table stakes. The interesting question is no longer whether chains will digitise, it's who consolidates the patient relationship.
The Sigma merger is the structural wildcard. Three of the five biggest chains now share an owner. If that group unifies its digital and data infrastructure across Chemist Warehouse, Amcal, and DDS, it builds something no single banner could, scale, data, and reach in one stack. That's the development to watch over the next 12 to 18 months.
Meanwhile TerryWhite keeps extending its ecosystem, Priceline brings its services layer live, and the value end of the market quietly gets the same digital plumbing as the premium end. Retail price is becoming a commodity. Value is moving upstream, to health management, data, and convenience.
For healthtech vendors, the message is simple. Focus on clinical depth, on making the patient experience genuinely good, and on enabling pharmacists. The chains are investing in all three. The ones with better partners will win market access and data advantage. The window to be that partner is open now.
This is the 30,000-foot view. If you need the detail, who's partnering with whom, where the white space actually is, which chain to target and how, that's what Clinical Advisors is for. Want the deeper analysis? Let's talk. Terry Cornick is a healthtech strategist and the founder of Clinical Advisors, current as of June 2026.
